Jill Cottel, MD - Vitamin D and Autoimmune Disease: A Systematic Review of the Literature (2017 Conference) (LDN, low dose naltrexone)

Samyadev Datta, MD - Pharmacology of Low dose Naltrexone in Chronic Pain Management (2019 Conference) (LDN, low dose naltrexone)

Samyadev Datta, MD discusses LDN and ultra-low dose naltrexone (ULDN) to treat chronic pain and inflammatory/autoimmune conditions. He presents on the history and pharmacology of naltrexone, forms in which LDN can be prepared. Several case studies on pain are presented

Karalyn - New Zealand: Myasthenia Gravis (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Karalyn from New Zealand shares her Myasthenia Gravis and Low Dose Naltrexone (LDN) story. 

Jan - Netherlands: Myasthenia Gravis (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Flora - Scotland: Myasthenia Gravis (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Flora from Scotland takes Low Dose Naltrexone  (LDN) for Myasthenia Gravis (MG). 

Linda Elsegood: I'd like to introduce Darlene from the United States who takes LDN. Thank you for joining me, Darlene.

Darlene: I had lupus for many years and started back when I was raising my young children, and I felt fatigued and feel all the time. So I found the LDN.

Linda Elsegood: Before we start Darlene, what are the conditions do you have?

What autoimmune conditions that you use LDN for?

Darlene: Well, I use it for Myasthenia Gravis also, another autoimmune disease.

Jill Cottel, MD - Treating the Zebras in Primary Care (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Cottel shares case studies of patients:

36 year old woman with Ehlers-Danlos Syndrome. This lady was started on Low Dose Naltrexone (LDN) at 1.5mg, increased to 3 mg and found she lost her earlier improvement but on going down to a much lower dose she improved significantly.